Strategic investments strengthen resilience and service capabilities for innovative injectable therapies Ravensburg, ...

Christy Eatmon, Global Steriles SME, Thermo Fisher Scientific, Pharma Services Group, discusses how Thermo Fisher Scientific ...

Alcami, a CDMO, has appointed biologics industry veteran Will Isom as Vice President of Laboratory Services Sales. The ...

Neuland Laboratories has officially launched the first module of its commercial peptide manufacturing facility in Hyderabad, ...

Shilpa Biologicals Private Limited has entered into an exclusive strategic licensing and commercialization agreement with ...

Of that new CDMO capacity, 71% by volume is large-scale stainless steel, she said, but this is being installed by just a ...

This week on "The Friday Brief," we wrap up our 25th year of the Contract Pharma Contracting & Outsourcing Conference.

The first-ever CPHI Sustainability Summit brings together key stakeholders from the pharmaceutical and healthcare industries ...

The approved variation enables Upperton to commence GMP manufacture of sterile investigational medicinal products from the purpose-built facility, expanding the company’s integrated development and ...

Decisions around trial design, regulatory strategy, and manufacturing planning ultimately determine whether a therapy reaches patients.

Shilpa CD MO, a dedicated complex small-molecule contract development and manufacturing organization is launching at CPHI Milan. The new brand, separate from parent company Shilpa Medicare, provides a ...

This week on "The Friday Brief," companies put down roots on both sides of the Atlantic, expanding their capabilities in a number of areas.